Elevian Company

Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.


Connections from

Headquarters: Allston, Massachusetts, United States
Investors Number: 9
Technology: Regenerative Medicine
Last Funding Type: Seed
Funding Status: Seed
Employee Number: 1-10
Total Funding: 24333889
Number Of Exists: Seed
Last Funding Date: 2020
Investor Type: Company
Founded Date: 2017
Industry: Biopharma, Biotechnology
Estimated Revenue: $1M to $10M